Gene · 3914
Papers1,750
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,750
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Four-Gene Signature Associated with Radioresistance in Head and Neck Squamous Cell Carcinoma Identified by Text Mining and Data Analysis. | Comput Math Methods Med | 2022 | 36203528 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36197221 | PubTator, text mining | PubMed |
| P4HA2: A link between tumor-intrinsic hypoxia, partial EMT and collective migration. | Adv Cancer Biol Metastasis | 2022 | 36187341 | PubTator, text mining | PubMed |
| Human fetal skin derived merkel cells display distinctive characteristics in vitro and in bio-engineered skin substitutes in vivo. | Front Bioeng Biotechnol | 2022 | 36185452 | PubTator, text mining | PubMed |
| Semi-3D cultures using Laminin 221 as a coating material for human induced pluripotent stem cells. | Regen Biomater | 2022 | 36176714 | PubTator, text mining | PubMed |
| Mechanotransduction through adhesion molecules: Emerging roles in regulating the stem cell niche. | Front Cell Dev Biol | 2022 | 36172276 | PubTator, text mining | PubMed |
| Identification and verification of CCNB1 as a potential prognostic biomarker by comprehensive analysis. | Sci Rep | 2022 | 36167975 | PubTator, text mining | PubMed |
| Primary failure of tooth eruption: Etiology and management. | Jpn Dent Sci Rev | 2022 | 36159186 | PubTator, text mining | PubMed |
| Bioinformatic Analysis for Mucoepidermoid and Adenoid Cystic Carcinoma of Therapeutic Targets. | Vaccines (Basel) | 2022 | 36146635 | PubTator, text mining | PubMed |
| Real and Simulated Microgravity: Focus on Mammalian Extracellular Matrix. | Life (Basel) | 2022 | 36143379 | PubTator, text mining | PubMed |
| A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9. | Int J Mol Sci | 2022 | 36142828 | PubTator, text mining | PubMed |
| The Multi-Omic Landscape of Primary Breast Tumors and Their Metastases: Expanding the Efficacy of Actionable Therapeutic Targets. | Genes (Basel) | 2022 | 36140723 | PubTator, text mining | PubMed |
| Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your Eyes. | Biomedicines | 2022 | 36140224 | PubTator, text mining | PubMed |
| Ribosome-Directed Therapies in Cancer. | Biomedicines | 2022 | 36140189 | PubTator, text mining | PubMed |
| Gene mutations in sporadic lymphangioleiomyomatosis and genotype-phenotype correlation analysis. | BMC Pulm Med | 2022 | 36117164 | PubTator, text mining | PubMed |
| Identification of alanine aminotransferase 1 interaction network via iTRAQ-based proteomics in alternating migration, invasion, proliferation and apoptosis of HepG2 cells. | Aging (Albany NY) | 2022 | 36107005 | PubTator, text mining | PubMed |
| Single-cell profiling reveals molecular basis of malignant phenotypes and tumor microenvironments in small bowel adenocarcinomas. | Cell Discov | 2022 | 36104333 | PubTator, text mining | PubMed |
| COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa. | Front Med (Lausanne) | 2022 | 36091706 | PubTator, text mining | PubMed |
| Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma. | Front Cell Dev Biol | 2022 | 36081907 | PubTator, text mining | PubMed |
| A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer. | Mol Cancer | 2022 | 36076232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3914/papers?page=17